Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycobacterial pathogenesis: a historical perspective

F M Collins1

  • 1Laboratory of Mycobacteria, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20852, USA. collinsf@a1.cber.fda.gov

Frontiers in Bioscience : a Journal and Virtual Library
|July 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Giant Dermoid Cyst.

The Indian medical gazette·2017
Same author

The Treatment of Cervical Glandular Tuberculosis.

The Indian medical gazette·2017
Same author

Adherent Fallopian Tube Causing Intestinal Strangulation.

British medical journal·2010
Same author

'Rescue' of mini-genomic constructs and viruses by combinations of morbillivirus N, P and L proteins.

The Journal of general virology·2005
Same author

Susceptibility of mice deficient in the MHC class II transactivator to infection with Mycobacterium tuberculosis.

Scandinavian journal of immunology·2003
Same author

Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products.

Tuberculosis (Edinburgh, Scotland)·2001
Same journal

The CD44 protein family: roles in embryogenesis and tumor progression.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Four varieties of voltage-gated proton channels.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Lurie's tubercle-count method to test TB vaccine efficacy in rabbits.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Optical spectroscopy of breast biopsies and human breast cancer xenografts in nude mice.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

The colostrum-deprived, artificially-reared, neonatal pig as a model animal for studying rotavirus gastroenteritis.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Action of polypeptide growth factors in colon cancer; development of new therapeutic approaches.

Frontiers in bioscience : a journal and virtual library·2017
See all related articles

Tuberculosis remains a global health crisis, with limited understanding of how Mycobacterium tuberculosis evades immune defenses. Developing new vaccines requires innovative approaches to antigen presentation and a deeper knowledge of pathogenesis.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Tuberculosis (TB) persists globally despite available treatments and BCG vaccine.
  • Mycobacterium tuberculosis evades host defenses, leading to progressive lung infection.
  • Latent TB infection establishes lifelong immunity in most, but its immune mechanisms are unclear.

Purpose of the Study:

  • To investigate the mechanisms by which Mycobacterium tuberculosis evades host immune defenses.
  • To understand the role of immune mediators in establishing latent TB infection.
  • To identify new strategies for developing improved TB vaccines.

Main Methods:

  • Review of existing literature on TB pathogenesis and immune responses.
  • Analysis of cellular mediators and cytokines involved in TB immunity.

Related Experiment Videos

  • Exploration of molecular biology advancements for antigen presentation.

    • Main Results:

    • Limited understanding of Mycobacterium tuberculosis immune evasion mechanisms.
    • Inconsistent efficacy of the BCG vaccine in preventing TB.
    • Gaps in knowledge regarding immune responses during latent TB establishment.

    Conclusions:

    • Urgent need for improved TB vaccines for prevention and therapy.
    • Limited understanding of pathogenesis and bacterial components hinders vaccine development.
    • Innovative antigen presentation strategies are crucial, leveraging molecular biology.